4C Medical’s Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit
Thursday, 10 August 2017
4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive therapies for structural heart disease, today announced that its medical device therapy for mitral regurgitation (MR) was featured in the Innovation Summit at Cardiovascular Innovations (CVI) 2017 held August 2, 2017 in Denver, CO. 4C Medical is developing the first MR therapy that preserves
- Published in Health & life sciences
No Comments